Top banner. ILARIS® (canakinumab).

Article
2 mins

Periodic fever syndromes

Article
- 25 Feb 2025
2 mins
Top banner. ILARIS® (canakinumab).

Article
2 mins

Familial Mediterranean fever (FMF)

Article
- 25 Feb 2025
2 mins

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.